Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Substrate Ablation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02083016
What this trial is testing

Ultra-high Density Mapping With Multielectrode Catheter vs Conventional Point by Point Mapping for Ventricular Tachycardia Substrate Ablation

Who this might be right for
Ventricular Tachycardia
Hospital Clinic of Barcelona 20
Not applicableNot Yet RecruitingNCT06765746
What this trial is testing

Repolarization and Activation Mapping in Ventricular Tachycardia Ablation: the REDEMPTION Study

Who this might be right for
Ventricular Tachycardia Ablation
Universitair Ziekenhuis Brussel 40
Not applicableStudy completedNCT00919373
What this trial is testing

Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) Therapy

Who this might be right for
Ventricular TachycardiaCoronary Artery DiseaseLeft Ventricular Dysfunction
Abbott Medical Devices 110
Not applicableNot Yet RecruitingNCT07573579
What this trial is testing

Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia Substrate

Who this might be right for
Ventricular Tachycardia (VT)
Liverpool Heart and Chest Hospital NHS Foundation Trust 40
Not applicableUnknownNCT05873920
What this trial is testing

Atrial Fibrillation and Diabetes Mellitus

Who this might be right for
Atrial FibrillationArrhythmias, CardiacHeart Diseases+2 more
Heart and Diabetes Center North-Rhine Westfalia 50
Not applicableWithdrawnNCT02216760
What this trial is testing

Using Ripple Mapping to Guide Substrate Ablation of Scar Related Ventricular Tachycardia.

Who this might be right for
Monomorphic Ventricular TachycardiaMyocardial InfarctionDilated Cardiomyopathy
Imperial College London
Not applicableActive Not RecruitingNCT03347227
What this trial is testing

Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Ottawa Heart Institute Research Corporation 510
Not applicableStudy completedNCT04041778
What this trial is testing

'Understanding the Electrophysiological Substrate Underlying Persistent Atrial Fibrillation Study II (USURP AF- Study II)'

Who this might be right for
Atrial Fibrillation MechanismsPersistent Atrial FibrillationSubstrate Ablation+2 more
University of Leicester 17
Not applicableWithdrawnNCT05828667
What this trial is testing

The STandard Versus ImAging SuBstrate Aided Ablation in Severe Left VEntricular Dysfunction VT.

Who this might be right for
Cardiovascular Diseases
University of Pennsylvania
Not applicableStudy completedNCT05086510
What this trial is testing

Ablation Targets of Scar-related Ventricular Tachycardia Identified by Dynamic Functional Substrate Mapping

Who this might be right for
Tachycardia, Ventricular
Ain Shams University 40
Not applicableLooking for participantsNCT07358611
What this trial is testing

Non-invasive Mapping-Guided Atrial Fibrillation Ablation

Who this might be right for
Atrial Fibrillation (AF)
Hospital Clinic of Barcelona 30
Not applicableStudy completedNCT03421834
What this trial is testing

Impact of PREVENTIVE Substrate Ablation of Coronary Chronic Total Occlusion on Implantable cardioVerTer-Defibrillator Interventions

Who this might be right for
Ventricular TachycardiaIschemic Cardiomyopathy
University Medical Centre Ljubljana 60
Not applicableLooking for participantsNCT07580547
What this trial is testing

Sex-Based Disparities in the Electrophysiological Substrate for Atrial Fibrillation and Its Impact on Clinical Outcomes

Who this might be right for
Atrial Fibrillation (AF)
Anat Milman 100
Not applicableLooking for participantsNCT05633303
What this trial is testing

Personalised Ablation Strategies in AF

Who this might be right for
Atrium; Fibrillation
Barts & The London NHS Trust 160
Not applicableStudy completedNCT01182389
What this trial is testing

Early Robotic Ablation by Substrate Elimination of Ventricular Tachycardia

Who this might be right for
Ventricular Tachycardia
Imperial College London 51
Not applicableEnded earlyNCT02130765
What this trial is testing

Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia

Who this might be right for
Monomorphic Ventricular Tachycardia
Abbott Medical Devices 64
Not applicableStudy completedNCT03862339
What this trial is testing

The SoundScar Study The SOUNDSCAR Study

Who this might be right for
Ventricular TachycardiaIschemic Cardiomyopathy
Liverpool Heart and Chest Hospital NHS Foundation Trust 38
Not applicableUnknownNCT02547584
What this trial is testing

Impact of Anxiety on Cardiac Substrate Modification in Women With Atrial Fibrillation Undergoing Catheter Ablation

Who this might be right for
Atrial Fibrillation
Texas Cardiac Arrhythmia Research Foundation 152
Large-scale testing (Phase 3)Study completedNCT01045668
What this trial is testing

Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation

Who this might be right for
Ventricular Tachycardia
Texas Cardiac Arrhythmia Research Foundation 120
Not applicableLooking for participantsNCT05643209
What this trial is testing

Brugada Syndrome Substrate Characterization and Ablation

Who this might be right for
Brugada Syndrome
Maria Cecilia Hospital 20
Next Page